Baroness Amos to lead NHS maternity and neonatal investigation
Mr Streeting has been meeting bereaved and harmed families who have been let down by maternity and neonatal services across the country, including in some of the worst affected trusts, DHSC added.
In June, he announced that a national investigation into 'systemic' failures in NHS maternity care had been launched by the Government after families were 'gaslit' in their search for the truth.
Baroness Amos is master of University College, Oxford, and was a UK Government minister and a senior official at the United Nations.
Mr Streeting said: 'I have been appalled by the many harrowing stories I've heard from mothers and fathers let down by the NHS.
'Families asked for fresh eyes, independence and compassion – and that's why I've appointed Baroness Amos. Valerie has an outstanding record of leadership and driving change, nationally and internationally. She will work closely with families to uncover the truth, confront problems and drive the improvements needed so every woman and baby receives safe, high-quality care.
'Through our Plan for Change, we will rebuild the NHS to ensure no family suffers like this again.'
Baroness Amos said: 'I will carry the weight of the loss suffered by families with me throughout this investigation. I hope that we will be able to provide the answers that families are seeking and support the NHS in identifying areas of care requiring urgent reform.'
The investigation will look at up to 10 services in the country. It will also review the maternity and neonatal system, bringing together the findings of past reviews into one national set of actions, the DHSC said.
It will begin work this summer and produce an initial set of national recommendations by December.
The 10 maternity and neonatal units will be decided by Baroness Amos and her team, alongside the terms of reference of the investigation, which are being developed with families who have experiences of maternity and neonatal care, including in Leeds, Sussex and Nottingham, the DHSC added.
The investigation is separate from the National Maternity and Neonatal Taskforce, which will be made up of a panel of experts and families, and chaired by Mr Streeting.
Gill Walton, chief executive of the RCM, said: 'We are pleased to hear of the appointment of Baroness Amos as chair of the rapid review. She has a reputation for taking a thoughtful and strategic approach and we welcome her fresh insight into maternity and neonatal safety.
'It is absolutely vital, though, that this review gets under way quickly. When he announced it in June, we welcomed Wes Streeting's commitment to publishing the review by Christmas, a promise he repeated at the Progress in Partnership summit on maternity and neonatal safety last month.
'However, we are already halfway through August, with no terms of reference, no sense of the trusts who are likely to be part of the review or no clarity on how the review will be conducted.
'Every woman and family should leave maternity and neonatal services whole, happy and healthy, and every member of maternity staff should start and end their shift knowing they have provided safe, good-quality care.
'At the moment, that simply isn't the case. Previous reviews and countless Care Quality Commission reports have flagged the same the systemic failings that are at the heart of the issues facing maternity and neonatal care issues time and time again: unsafe staffing, poor workplace cultures, and not listening to women.
'In spite of that, there has been no forward movement. Wes Streeting promised to change that. Thousands of midwives and maternity support workers, and the whole of the maternity community, are desperate for him to keep that promise and deliver the change we all want to see.'
The RCM has also urged the review to look at examples of good maternity care, as well as where services are not meeting standards of care.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scotsman
24 minutes ago
- Scotsman
The things to consider before getting cosmetic surgery abroad
The government is bringing in new regulations in the UK as part of a cosmetic surgery crackdown 💉 Sign up to our daily newsletter Sign up Thank you for signing up! Did you know with a Digital Subscription to Edinburgh News, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... More people are turning to social media to research cosmetic surgery abroad. People are travelling for procedures like hair transplants and dental work. However, when something goes wrong, the NHS is left with the cost. More people than ever are turning to social media for information about cosmetic surgeries abroad, travelling for procedures like hair transplants or dental work. However, when things go wrong, the NHS is often left to pick up the cost. To help ensure patients have trustworthy information, the government and TikTok have partnered with medical influencers to create content showing the risks and advising on how to make trips as safe as possible. Advertisement Hide Ad Advertisement Hide Ad It comes after the government announced new regulations on cosmetic procedures in the UK. The highest-risk procedures, such as non-surgical Brazilian butt lifts, can only be carried out by qualified, specialised healthcare professionals, registered with the Care Quality Commission. Whilst measures will also include a licensing scheme for lower-risk procedures such as Botox and fillers, alongside minimum age restrictions. The government is also bringing in new regulations for cosmetic procedures in the UK. | Pexels, cottonbro studio Health Minister Karin Smyth said: 'Too many people are being left with life-altering injuries after going abroad for medical procedures, without access to proper advice or safeguards, often drawn in by deals too good to be true and promoted by influencers - some of whom have never been to the practice in question. 'By partnering with TikTok, we're helping people make safer, more informed choices before they go under the knife - wherever that may be. Advertisement Hide Ad Advertisement Hide Ad 'Through our Plan for Change, we're determined to protect patients, ease pressure on the NHS and make sure taxpayers are not left paying the price when things go wrong.' What should you consider before getting cosmetic surgery abroad? There are many things to consider before travelling abroad for cosmetic procedures or surgery. The new advice is calling on potential patients to talk with a UK doctor first and research the clinic they plan to travel to. Advertisement Hide Ad Advertisement Hide Ad Check if the clinic is registered and the surgeon's credentials. The NHS advises that before deciding on a clinic, you should find out how surgeons and clinics are regulated in your chosen country and how standards are enforced. Before the procedure, you should have two consultations with the surgeon. This gives you a two-week cooling-off period, which is normally two weeks in the UK. What should you ask your surgeon? In these consultations, the surgeon should explain what the procedure involves, the limitations, alternatives, and any risks or complications. They should also be able to show you before-and-after pictures of their work. Plan for any risks or complications, ask what insurance the clinic or surgeon has and if it will cover you, find out what your travel insurance covers and how you'll get home in the case of an emergency, and most importantly, how much this will cost. Advertisement Hide Ad Advertisement Hide Ad How to check if a person is qualified? Each country will have its registration system and accreditation body. In England, all hospitals and clinics that provide cosmetic surgery must be registered with the Care Quality Commission (CQC). You can find out more about travelling for medical or cosmetic reasons at
Western Telegraph
31 minutes ago
- Western Telegraph
Mounjaro prices double as weight loss jab popularity soars
US-based Eli Lilly says a 5mg dose will nearly double from £92 to £180 from September 1, while a 15mg pen will rise from £122 to £330. A Lilly spokesperson said: 'Following a review, Lilly will increase the UK list price for Mounjaro (tirzepatide) from 1 September to address pricing inconsistencies compared to other developed countries, including in Europe. We have reached an agreement with the NHS to ensure continued supply and patient access." The statement continues: 'While Lilly does not determine the prices that private healthcare providers set, we are working with them to maintain patient access. The UK was one of the first countries where Lilly launched Mounjaro, and our priority was to bring it to patients as quickly as possible during a time of limited supply of GLP-1 RA treatments for type 2 diabetes. 'At launch, Lilly agreed to a UK list price that is significantly below the European average to prevent delays in NHS availability." More than 1.5 million people in the UK are believed to be using weight-loss medication each month, with most buying the jabs from private pharmacies. Mounjaro users report surprising side effect - pharmacists share their tips — Bucks Free Press (@bucksfreepress) August 8, 2025 This comes as the Government has joined forces with Eli Lilly in a bid to tackle obesity. The move could see patients accessing care at pharmacies or by using online platforms. The £85 million programme from Eli Lilly and the Department for Science, Innovation and Technology (DSIT) has been designed to look at how obese patients can access weight management care more easily. This includes through community services, in pharmacies and online. Using these tools, eligible patients could be treated 'in a matter of months', according to Health Secretary Wes Streeting. Under the agreement, the Government will contribute up to £50 million in UK-wide investment. Meanwhile, Eli Lilly will back the programme with £35 million, and NHS organisations will be able to apply for a share of the funding. Recommended reading: Mounjaro warning as pens ruined by heatwave temperatures This comes as users are risking having to throw away perfectly good Mounjaro pens as they have overheated in the recent heatwave. Improper storage of Ozempic, Wegovy and Mounjaro during a heatwave could destroy the active ingredient in these jabs, potentially wiping out their effects entirely, even if the medication looks completely normal. 'We recommend treating your weight-loss pen the same way you'd treat insulin or any critical medication,' says Danielle Brightman, Clinical Director at Numan. 'When in doubt, don't risk it. Speak to a healthcare professional and arrange a replacement.' 8 tips to protect Mounjaro and other weight-loss injections during hot weather Use a medical-grade cool bag. Transport your pen in a proper, insulated container designed for sensitive medications. Don't use improvised ice packs that might freeze the pen by accident. Never leave your pen in hot places. Even 10 minutes in a parked car or on a sunny kitchen counter could expose it to damaging heat if out of its delivery packaging or unrefrigerated. Always check the environment before setting it down. Store below 30°C once in use. Once opened and if not refrigerated, keep your pen in a shaded, ventilated area, away from heat sources, windows, and radiators. If you live in a flat or home without air conditioning, keep the pen in a bedroom or hallway that doesn't heat up from direct sun. Avoid storing near exterior walls if the property retains heat. Follow the usage timeline carefully. The storage instructions between medications. Wegovy after first use can last 6 weeks below 30 degrees then needs to be disposed of, whereas Mounjaro has a shorter time of 30 days below 30 degrees before needing to be disposed of. Stick to that timeframe, and if you're unsure whether it's still safe, consult your provider. Use a fridge thermometer at home. Fridge temperatures can fluctuate, especially in older models or over-packed shelves. A simple digital fridge thermometer can help ensure your pen is always stored between 2–8°C before first use. Planning to travel? Use airline-friendly cooling cases. If you're flying or taking long journeys, consider TSA-approved insulated medication pouches with cooling gel packs. Always store the pen in carry-on luggage, not checked baggage, as cargo holds can get hot or cold. Set storage reminders on your phone. If you're prone to forgetting where you left your pen, set daily reminders to check if it's stored properly, especially during heatwaves or while travelling. Don't store near appliances or steam sources. Keep pens away from kettles, toasters, ovens, dishwashers, and anywhere that might experience sudden heat or humidity, especially in small kitchens or shared spaces. Injections like Ozempic, Wegovy, and Mounjaro are now widely used across the UK for appetite control and sustainable weight management. But despite their growing popularity and increasing availability now through the NHS, most patients don't realise the strict temperature guidelines that must be followed to keep these drugs effective. 'We speak to patients every day who are using GLP-1s for the first time,' says Danielle. 'With temperatures set to soar again this summer, it's crucial we raise awareness about safe medication storage. Heat damage isn't always obvious, but it can have a huge impact on effectiveness and safety."
.png%3Fwidth%3D1200%26auto%3Dwebp%26quality%3D75&w=3840&q=100)
Evening Standard
31 minutes ago
- Evening Standard
South London hospital staff set to strike over 'Mickey Mouse' contracts
The workers, all now directly employed by the NHS, are calling for the same pay and conditions as colleagues on the national Agenda for Change (AfC) framework, which sets standard rates for most NHS staff. UVW says that despite being brought back in-house more than four years ago, they still receive lower pay, less annual leave, inferior pensions and no enhancements for night or weekend work.
